Efficacy of repetitive transcranial magnetic stimulation in Parkinson's disease: A systematic review and meta-analysis of randomised controlled trials
Tóm tắt
Từ khóa
Tài liệu tham khảo
Nemade, 2021, An update on medical and surgical treatments of Parkinson's disease, Aging Dis, 12, 1021, 10.14336/AD.2020.1225
Kirmani, 2021, Neurological and neurodegenerative disorders: novel concepts and treatment, Aging Dis, 12, 950, 10.14336/AD.2021.0530
Hendricks, 2021, A systematic review of Parkinson's disease cluster analysis research, Aging Dis, 12, 1567, 10.14336/AD.2021.0519
Zhu, 2021, The pathogenesis and treatment of cardiovascular autonomic dysfunction in Parkinson's disease: what we know and where to go, Aging Dis, 12, 1675, 10.14336/AD.2021.0214
Gilat, 2021, A systematic review on exercise and training-based interventions for freezing of gait in Parkinson’s disease, npj Parkinson’s Disease, 7, 81, 10.1038/s41531-021-00224-4
Zhu, 2021, Association of visual impairment with risk for future Parkinson's disease, eClin Med, 42
Connolly, 2014, Pharmacological treatment of Parkinson disease, JAMA, 311, 1670, 10.1001/jama.2014.3654
Fahn, 2008, The history of dopamine and levodopa in the treatment of Parkinson's disease, Movement Disord, 23, S497, 10.1002/mds.22028
Turcano, 2018, Levodopa-induced dyskinesia in Parkinson disease, Neurology, 91, e2238, 10.1212/WNL.0000000000006643
Sanches, 2021, Past, present, and future of non-invasive brain stimulation approaches to treat cognitive impairment in neurodegenerative diseases: time for a comprehensive critical review, Front Aging Neurosci, 12, 578339, 10.3389/fnagi.2020.578339
Zhu, 2021, “Hot cross bun” is a potential imaging marker for the severity of cerebellar ataxia in MSA-C, npj Parkinson’s Disease, 7, 15, 10.1038/s41531-021-00159-w
Zhu, 2020, Various diseases and clinical heterogeneity are associated with “hot cross bun”, Front Aging Neurosci, 12, 592212, 10.3389/fnagi.2020.592212
Lin, 2018, Gut microbiota in patients with Parkinson's disease in southern China, Parkinsonism Relat D, 53, 82, 10.1016/j.parkreldis.2018.05.007
Yang, 2020, Contra-directional expression of plasma superoxide dismutase with lipoprotein cholesterol and high-sensitivity C-reactive protein as important markers of parkinson’s disease severity, Front Aging Neurosci, 12, 53, 10.3389/fnagi.2020.00053
Wang, 2021, The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options, Brain, 144, 2571, 10.1093/brain/awab156
Yang, 2021, Two heterozygous progranulin mutations in progressive supranuclear palsy, Brain, 144, e27, 10.1093/brain/awaa428
Gao, 2021, Multimodal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson’s disease, Brief Bioinform, 22, 1, 10.1093/bib/bbaa244
Que, 2021, Dl-3-n-butylphthalide rescues dopaminergic neurons in Parkinson’s disease models by inhibiting the NLRP3 inflammasome and ameliorating mitochondrial impairment, Front Immunol, 12, 794770, 10.3389/fimmu.2021.794770
Zou, 2017, Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units, Cell Death Dis, 8, e2854, 10.1038/cddis.2017.240
Brunoni, 2017, Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes, Jama Psychiat, 74, 143, 10.1001/jamapsychiatry.2016.3644
Milev, 2016, Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder, Can J Psychiatry, 61, 561, 10.1177/0706743716660033
Jankovic, 2008, Parkinson's disease: clinical features and diagnosis, J Neurol, Neurosurg Psychiatry, 79, 368, 10.1136/jnnp.2007.131045
Shin, 2019, Cerebellar repetitive transcranial magnetic stimulation for patients with essential tremor, Parkinsonism Relat D, 64, 304, 10.1016/j.parkreldis.2019.03.019
Chen, 2019, Invasive and noninvasive brain stimulation in parkinson's disease: clinical effects and future perspectives, Clin Pharmacol Ther, 106, 763, 10.1002/cpt.1542
Page, 2021, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ, 372, n71, 10.1136/bmj.n71
Li, 2020, High-frequency repetitive transcranial magnetic stimulation over the primary motor cortex relieves musculoskeletal pain in patients with Parkinson's disease: a randomized controlled trial, Parkinsonism Relat D, 80, 113, 10.1016/j.parkreldis.2020.07.006
Chung, 2020, Transcranial magnetic stimulation promotes gait training in parkinson disease, Ann Neurol, 88, 933, 10.1002/ana.25881
Mi, 2019, High-frequency rTMS over the supplementary motor area improves freezing of gait in Parkinson's disease: a randomized controlled trial, Parkinsonism Relat D, 68, 85, 10.1016/j.parkreldis.2019.10.009
Khedr, 2019, The effect of high-frequency repetitive transcranial magnetic stimulation on advancing parkinson's disease with dysphagia: double blind randomized clinical trial, Neurorehab Neural Re, 33, 442, 10.1177/1545968319847968
Cohen, 2018, Repetitive deep TMS for Parkinson disease, J Clin Neurophysiol, 35, 159, 10.1097/WNP.0000000000000455
Buard, 2018, Transcranial magnetic stimulation does not improve mild cognitive impairment in Parkinson's disease, Movement Disord, 33, 489, 10.1002/mds.27246
Yokoe, 2018, The optimal stimulation site for high-frequency repetitive transcranial magnetic stimulation in Parkinson's disease: a double-blind crossover pilot study, J Clin Neurosci, 47, 72, 10.1016/j.jocn.2017.09.023
Brys, 2016, Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease, Neurology, 87, 1907, 10.1212/WNL.0000000000003279
Makkos, 2016, High-frequency repetitive transcranial magnetic stimulation can improve depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study, Neuropsychobiology, 73, 169, 10.1159/000445296
Kim, 2015, Efficacy of cumulative high-frequency rTMS on freezing of gait in Parkinson's disease, Restor Neurol Neuros, 33, 521
Maruo, 2013, High-frequency repetitive transcranial magnetic stimulation over the primary foot motor area in parkinson's disease, Brain Stimul, 6, 884, 10.1016/j.brs.2013.05.002
Benninger, 2012, Controlled study of 50-Hz repetitive transcranial magnetic stimulation for the treatment of parkinson disease, Neurorehab Neural Re, 26, 1096, 10.1177/1545968312445636
Pal, 2010, The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study, Movement Disord, 25, 2311, 10.1002/mds.23270
Filipović, 2009, Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease, Movement Disord, 24, 246, 10.1002/mds.22348
Shulman, 2010, The clinically important difference on the unified Parkinson's disease rating scale, Archives Neurol, 67, 64, 10.1001/archneurol.2009.295
Fregni, 2005, Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature, J Neurol, Neurosurg Psychiatry, 76, 1614, 10.1136/jnnp.2005.069849
Elahi, 2009, Effect of transcranial magnetic stimulation on Parkinson motor function-Systematic review of controlled clinical trials, Movement Disord, 24, 357, 10.1002/mds.22364
Chou, 2015, Effects of repetitive transcranial magnetic stimulation on motor symptoms in parkinson disease, Jama Neurol, 72, 432, 10.1001/jamaneurol.2014.4380
Lefaucheur, 2020, Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014–2018), Clin Neurophysiol, 131, 474, 10.1016/j.clinph.2019.11.002
Lang, 2008, Dopaminergic potentiation of rTMS-induced motor cortex inhibition, Biol Psychiat, 63, 231, 10.1016/j.biopsych.2007.04.033
Regnault, 2019, Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort, J Neurol, 266, 1927, 10.1007/s00415-019-09348-3
Tosin, 2021, Does MDS-UPDRS provide greater sensitivity to mild disease than UPDRS in De Novo Parkinson's disease?, Movement Disord Clin Practice, 8, 1092, 10.1002/mdc3.13329
Lokhandwala, 2019, Correlation between PDQ-39 and MDS-UPDRS scores in a phase 3 randomized controlled trial of patients with Parkinson’s disease [abstract], Mov Disord, 34, S389
Gao, 2020, Freezing of gait in Parkinson’s disease: pathophysiology, risk factors and treatments, Transl Neurodegener, 9, 12, 10.1186/s40035-020-00191-5
Gao, 2019, Repetitive transcranial magnetic stimulation does not improve the sequence effect in freezing of gait [abstract], Mov Disord, 34, S263
Brusa, 2006, Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease, Clin Neurophysiol, 117, 1917, 10.1016/j.clinph.2006.03.033
Koch, 2009, Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease, Neurology, 73, 113, 10.1212/WNL.0b013e3181ad5387
Dagan, 2017, The role of the prefrontal cortex in freezing of gait in Parkinson's disease: insights from a deep repetitive transcranial magnetic stimulation exploratory study, Exp Brain Res, 235, 2463, 10.1007/s00221-017-4981-9
Srovnalova, 2012, The role of the right dorsolateral prefrontal cortex in the Tower of London task performance: repetitive transcranial magnetic stimulation study in patients with Parkinson's disease, Exp Brain Res, 223, 251, 10.1007/s00221-012-3255-9
Srovnalova, 2011, The role of the inferior frontal gyri in cognitive processing of patients with Parkinson's disease: a pilot rTMS study, Movement Disord, 26, 1545, 10.1002/mds.23663
Benninger, 2009, Safety study of 50Hz repetitive transcranial magnetic stimulation in patients with Parkinson's disease, Clin Neurophysiol, 120, 809, 10.1016/j.clinph.2009.01.012
Epstein, 2007, An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson's disease, Clin Neurophysiol, 118, 2189, 10.1016/j.clinph.2007.07.010
Boggio, 2005, Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression, Movement Disord, 20, 1178, 10.1002/mds.20508
Jiang, 2020, Effect of rTMS on Parkinson’s cognitive function: a systematic review and meta-analysis, Bmc Neurol, 20, 377, 10.1186/s12883-020-01953-4
Begemann, 2020, Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis, Psychol Med, 50, 2465, 10.1017/S0033291720003670
Lawrence, 2017, Cognitive training and noninvasive brain stimulation for cognition in Parkinson's disease: a meta-analysis, Neurorehab Neural Re, 31, 597, 10.1177/1545968317712468
Borenstein, 2010, A basic introduction to fixed-effect and random-effects models for meta-analysis, Res Synth Methods, 1, 97, 10.1002/jrsm.12
Xie, 2015, Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in Parkinson disease: a meta-analysis of randomized controlled clinical trials, Neurol Sci, 36, 1751, 10.1007/s10072-015-2345-4
Lesenskyj, 2018, Treating refractory depression in Parkinson’s disease: a meta-analysis of transcranial magnetic stimulation, Transl Neurodegener, 7, 8, 10.1186/s40035-018-0113-0
Randver, 2018, Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex to alleviate depression and cognitive impairment associated with Parkinson's disease: a review and clinical implications, J Neurol Sci, 393, 88, 10.1016/j.jns.2018.08.014
McClintock, 2018, Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression, J Clin Psychiatry, 79, 35, 10.4088/JCP.16cs10905
Chaudhuri, 2009, Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment, Lancet Neurol, 8, 464, 10.1016/S1474-4422(09)70068-7
Oltra, 2022, Sex differences in brain and cognition in de novo Parkinson’s Disease, Front Aging Neurosci, 13, 791532, 10.3389/fnagi.2021.791532
Bohnen, 2014, Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease, Parkinsonism Relat D, 20, 1394, 10.1016/j.parkreldis.2014.10.008
Sun, 2012, Risk of Parkinson disease onset in patients with diabetes, Diabetes Care, 35, 1047, 10.2337/dc11-1511
Ong, 2017, Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease, J Neurol Sci, 377, 122, 10.1016/j.jns.2017.04.010
Horsager, 2020, Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study, Brain, 143, 3077, 10.1093/brain/awaa238
Herrero Babiloni, 2021, The effects of non-invasive brain stimulation on sleep disturbances among different neurological and neuropsychiatric conditions: a systematic review, Sleep Med Rev, 55, 10.1016/j.smrv.2020.101381
Huang, 2005, Theta burst stimulation of the human motor cortex, Neuron, 45, 201, 10.1016/j.neuron.2004.12.033
Di Lazzaro, 2010, The effects of motor cortex rTMS on corticospinal descending activity, Clin Neurophysiol, 121, 464, 10.1016/j.clinph.2009.11.007
Stefan, 2000, Induction of plasticity in the human motor cortex by paired associative stimulation, Brain, 123, 572, 10.1093/brain/123.3.572